MENU
UTHR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

United Therapeutics (UTHR) Earnings Date & Reports

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs... Show more

A.I. Advisor
published Earnings

UTHR is expected to report earnings to rise 10.86% to $7.35 per share on July 30

United Therapeutics UTHR Stock Earnings Reports
Q2'25
Est.
$7.35
Q1'25
Beat
by $0.10
Q4'24
Missed
by $0.49
Q3'24
Missed
by $0.14
Q2'24
Missed
by $0.63
The last earnings report on April 30 showed earnings per share of $6.63, beating the estimate of $6.53. With 416.70K shares outstanding, the current market capitalization sits at 14.43B.
View a ticker or compare two or three
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com